General Flashcards

1
Q

How does Folate accelerate cancer cell growth?

A

Folate provides substrates for DNA synthesis and accelerates cancer cell proliferation and Tumor expanstion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cancer Staging

A

T: grade reflects the size and extent of the tumor
N: grade is for the extent of spread to local lymph
M: grade indicates the presence or absences of distant metastasis
Number: 0 to each letter indicates the size or extent of the primary cancer and extent of cancer spread

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Grade

A

measures how abnormal the cancer cell looks under microscope (differentiation)
-ones that look abnormal or more differentiated and tend to grow and spread fast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Grades

A

Gx: grade cannot be assessed
G1: Well differentiated (Low grade)
G2: moderately differentiated (intermediated)
G3: poorly differentiated (high grade)
G4: undifferentiated (high grade)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Grade -Primary Tumor (t)

A

Tx: tumor cannot be visible by imaging
To: No evidence of tumor
Ts: carcinoma in situ (CIS) abnormal cells are present but not spread to neighboring tissues
T1: Tumor not palpable or visible imaging
T2: tumor confirmed by primary cancer site
T3: tumor extends neighboring cancer sites
T4: metastatic disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Grade: Lymph Node (N)

A

NX: regional lymph nodes cannot be evaluated
N0 no regional lymph node involvement
N1-N3: Involvement of regional lymph nodes (number of lymph notes indicates extent of spread)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Distant Metastasis (M)

A

Grade:
Mx: distent metastatic cannot be evaluated
M0: No distant metasis
M1: Distant metastasis present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

3 stages of cancer cachexia

A
  1. precachexia -wt loss, anorexia, progression depends on cancer type and stage.
  2. Cachexia = wt loss of > 5% over 6 months, BMI < 20 with > 2% weight loss, sarcopenia and > 2% weight loss, reduced food intake
  3. Refractory cachexia-active metabolism, management of weight loss not possible , ve;ry advanced, unresponsive to cancer tx
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Energy needs

A

Cancer Repletion (weight gain): 30-35 kcals/Kg
cancer, inactive (nonstressed): 25-30 kcals/Kg
Cancer, hypermetabolic (stressed): 35 kcals/Kg
Sepsis: 25-30 kcals/Kg
BMT: 30-35 kcals/Kg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are functional foods?

A

Whole foods along with fortified, enrich or enhanced foods that have a potentially beneficial diet on a regular basis at effective levels based on significant standards of evidence

example: Flaxseed: omega 3 FA, amino acid, soluble and insoluble fiber

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Tumor Burden or Tumor Load

A

Definition: the size of the tumor or the amount of cancer in the body
Effects on response: As tumor mass increase in size its growth rate can slow thus reducing effectiveness of cancer treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Tumor growth rate

A

Definition: the proportion of cancer cells within the tumor that are growing and dividing to form a new cancer cell

Effects on response: Growing tumors usually are more responsive to treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Drug Resistance

A

Definition: the failure of cancer cells to respond to a drug used to kill or weaken them

effects on response: cancer cells may be resistant at the beginning of treatment or may develop resistance after exposure to treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cancer therapy approaches:

A

Prevention
preventative surgery
Adjuvant therapy
Definitive therapy
Neoadjuvant therapy
Palliation
Prophylactic therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cancer Therapy Approach: Prevention

A

Goal: use of medicines or other agents to reduce the risk of cancer or delay its development

Examples: hormone therapy (antiestrogen agent) to reduce the risk of breast Ca in a women who are at high risk, Immunization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cancer Therapy approach: Preventative surgery

A

Goals: use surgery to reduce the risk of cancer or delay its development

Example: Total colectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Cancer therapy approach: adjuvant therapy

A

Goals: use of additional cancer treatment after the primary therapy to reduce the risk of cancer recurrence and to decrease the incidence

Example:
Chemo given after lobectomy for tx of lung Ca
Chemo, hormone therapy and monoclonal antibody therapy given after lumpectomy after Breast Ca tx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Cancer therapy approach: Definitive therapy

A

Goals: Use of radiation therapy as the primary tx modality with or without chemo

example:
Radiation therapy of prostate cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Cancer therapy approach: Neoadjuvant therpay

A

Goals: use of 1 or more tx modalities before the primary therapy to reduce the size of the primary tumor, improve the effectiveness of the surgery and decrease the incidence of metastatic disease

example: Chemo and external beam radiation therapy given before esophagectomy to treat Esophageal Ca (chemo before surgery)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Cancer therapy approach: Palliation

A

Goals: use of Ca treatment modalities when disease cure and control cannot be achieved to relieve side effects and symptoms caused by Ca and other illnesses to improve QOL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Cancer therapy approach: Prophylactic therapy

A

Goals: use of radiation therapy to relieve symptoms such as pain bleeding, obstruction

Example: Whole brain irradiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

5 phases of cell cycle

A

G0: resting phase
G1 (post mitotic phase) - cells begin the 1st phase of reproduction by synthesizing protein and RNA necessary for cell death
S: Synthesis phase- DNA is synthesized
G2: (premeiotic phase) cells prepare to divide
M: (mitotic phase); cells growth and protein production stops cellular energy is focused on the orderly division into 2 daughter cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Chemo Agents used
(cell cycle nonspecific)

A

Classified according to their mechanism of action and effect on cell reproduction.
Cell cycle nonspecific agents (are drugs that damage cell in all phases)

include:
- Alkylating agents
- Antitumor agents
- Antibiotic agents
- Hormone
- Nitrosources

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Chemo agents used
(Cell cycle specific)

A

-Antimetabolites (synthesis phase)
-Camptohecins (synthesis phase)
-Plant Alkaid’s and taxanes (mitosis phase)
-Miscellaneous agents (various phases)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

3 important facts in the delivery of the different chemo agents include:

A

-frequency of cycle (daily, weekly, every 14, 21 days)
-length of cycle (lasting minutes, days, years)
-number of cycles (determine by research and clinical trials)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

cell cycle nonspecific drug: Alkylating agents

A

cell cycles nonspecific agents: active throughout the cell cycle

Mechanism of action: interfere with DNA . base causing break in DNA helix strands and thus preventing DNA replication and transcriptions of RNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Bendasmustine (treande)

A

-Alkylating agent
-route: IV
Indication: CLL, NHL, B celll
side effects: mild N/V, fatigue, hypersensitivity infusion, TLS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Busulfan (myleran)

A

-Alkylating agent
-route: IV
-Indication: Chronic CML, SCT
-side effects: N/V/D, mucositis, adrenal insuff.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Carboplatin (paraplatin)

A

-Alkylating agent
-route: IV
indication: breast, bladder, cervix, endometrium, esophagus, germ HN, lung
side effects: N/V, renal toxicity, peripheral neuropathy, Taste change

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Camustine (BCNU)

A

-Alkylating agent
-Route: IV
-indication: brain ca, NHL, MM
-Side effects: N/V/ hepatic, renal and pulmonary toxicity

31
Q

Chlorambucil

A

-Alkylating agent
-Route: IV
-indication:CLL, HD, NHL, Breast
Side effects: N/V, hyperuricemia, pulmonary toxicity, skin rash, seizure in children

32
Q

Cisplatin

A

-Alkylating agent
-Route: IV
-Indication: Bladder, cervix, esophagus, HN, lung, prostate, Ovaries, stomach, NHL
-Side effects: N/V (acute and delayed); metallic taste, renal toxicity; Low: Mg, K and Ca , SIADH

33
Q

cyclophosphamide (cytoxan)

A

-Alkylating agent
-route: IV, Intrapleural (IP)
-Indication: breast, lungs, CLL, NHL, HD, MM
- Side effects: N/V, bladder and cardiac toxicity, SIADH

34
Q

Dacabazine

A

-Alkylating agent
-Route: IV
-Indication: HD, MM, Thyroid
-Side effects: N/V, flu like symptoms

35
Q

Ifosfamide

A

-alkylating agent
-Route: IV
-Indication: bladder, cervix, germ, HN, Lung NHL
-Side effects: N/V, anorexia, Bladder toxicity

36
Q

Mechlorethiamine

A

-alkylating agent
-Route: IV
-Indication: CLL, CML, HD, NHL
-Side effects: N/V hyperuricemia

37
Q

Melphalan

A

-Alkylating agent
-Route: IV, Oral
-Indication: breast, ovarian, MM,SCT, neuroblastoma
Side effects: N/V, mucositis, diarrhea

38
Q

Oxaliplatin

A

-Alkylating agent
-route: IV
-Indication: colorectal, pancreatic
-Side effects: Cold sensitivity, hepatic toxicity, neurotoxicity, N/V/D

39
Q

Temozolomide (temodar)

A

-Alkylating agent
-Route: oral
-Indication: glioblastoma
-Side effects: N/V, fatigue, HA, Hepatic toxicity; constpiation

40
Q

Thiotepa

A

-Alkylating agent
-Route: IV, IM, Intra thecal (IT)
-Indication: Bladder, breast, NHL, Ovarian
-Side effects: Mucositis, renal toxicity, taste change, N/V

41
Q

Cell Cycle specific drugs: Antimetabolites

A

Mechanism: interfere with DNA synthesis by acting as a false metabolites incorporated into the DNA strand or block essential enzyme’s

42
Q

Azacitidine

A

-antimetabolites
-Route: SC, IV
-Indication: CML,MDS
-Side effects: N/V/D, fatigue, Low K, renal toxicity, constipation

43
Q

Capecitabine (xeloda)

A

-antimetabolite
-Route: Oral
-indication: colon, esophagus, pancreas, rectum, metastatic breast cancer
-Side effects: N/V/D/F, hand foot syndrome

44
Q

Cytarabine

A

-antimetabolite
-route: IV,SC,IT, IM
-indication: ALL, APL, AML, CML, NHL
-side effects: N/V, mucositis, anorexia, neurotoxicity, hepatic and pulmonary toxicity

45
Q

Fludarabine

A

-Antimetabolite
-Route: IV
-indication: CLL, NHL,
-side effects: N/V/D, neurotoxicity

46
Q

Fluorouracil (5-FU)

A

-antimetabolite
-Route: IV, Topical
-Indication: breast, colon, rectum, ovaries, stomach
-Side effects: N/V/diarrhea, mucositis

47
Q

Gematabine (Gemzar)

A

-Antimetabolite
-Route: IV
Indication: Bladder, breast, lung, pancreas
side effects: N/V, pulmonary toxicity

48
Q

Hydroxyurea (hydrea)

A

-Antimetabolite
-Route: oral
-Indication: CML, Blood disorders, HN ovaries
-side effects: N/V/D mucositis

49
Q

Mercaptopurine (6-MP)

A

-antimetabolite
-Route: oral
-indication: ALL, APL, Crohns
-side effects: N/V mucositis, diarrhea, hepatic toxicity, hyperuricemia

50
Q

Methotrexate (MTX)

A

-Antimetabolite
-route: oral
-indication: Bladder, breast, HN, NHL, ALL, osteosarcoma
–Side effects: N, mucisities, oral and GI ulceration, renal and hepatic toxicity

51
Q

Pemetrexed (alimta)

A

-antimetabolite
-Route: IV
-Indication: Lung, mesothelioma
-Side effects: Fatigue, N/V/D,
-REQUIRES: Folate and B12 to reduce side effects

52
Q

Thiguanine (6-TG)

A

-antimetabolite
-Route: Oral
-Indication: AML,CML
-side effects: N/V mucositis, diarrhea, renal and hepatic toxicity

53
Q

Cell cycle specific drugs: Antitumor Antibiotics

A

mechanism: inhibit cells division by binding to DNA and interfering with RNA synthesis

54
Q

Bleomycin (blenoxane)

A

-Antitumor Antibiotics
-Route: IV, SC, IM
-Indication: HD, NHL, HN, SCC Skin, Cervix, vulva, testes, melanoma, malignant, pleural effusions
-Pulmonary or renal toxicity

55
Q

Doctinomycin (actinomycin)

A

-Antitumor antibiotics
-Route: IV
-Indication: Ewing sarcoma, Williams Tumor, Testicular Ca
-Side effects: N/V/ mucositis, diarrhea, anorexia

56
Q

Mitomycin

A

-antitumor antibiotic
-Route: IV
Indication: Anus, bladder, Breast, esophagus, HN, Lung, pancreas, stomach
side effects: N/V/D mucositis, anorexia, pulmonary and renal toxicity

57
Q

Classification: Anthracycline antibodies

A

mechanism of action: Inhibits cell division by binding to DNA and interfering with RNA synthesis
Antitumor drug

58
Q

Daunorubicin

A

-Anthracycline antitumor antibodies
-Route: IV
-Indication: ALL, AML, APL
-Side effects: N/V, diarrhea, mucositis, Anorexia, hyperuricemia, red urine

59
Q

Doxorubicin

A

-Anthracycline Antitumor Antibodies
-Route: IV
-Indication: Breast, Liver, lung, ovaries, prostate, stomach, NHL, HD, MM, ALL, AML, SCC, HN
-Side effects: N/V/D, mucositis, Anorexia, Red-orange urine

60
Q

Doxorubicin Liposomal (doxil)

A

-Anthracycline Antitumor Antibodies
-Route: IV
-Indication: Aids related sarcoma, breast, ovaries
-Side effects: Red-orange urine, N/V/D/M

61
Q

Epirubicin (ellence)

A

-Anthracycline Antitumor Antibodies
-Route: IV
-Indication: Breast
-Side effects: Red-orange urine, N/V/D/M

62
Q

Idarubicin (idamycin)

A

-Anthracycline Antitumor Antibodies
-Route: IV
-Indication: AML, ALL, CML, MDS
-Side effects: Red urine, N/V/D/M

63
Q

Classification: Epipodophyllotoxins

A

mechanism of action: damage the cell prior to mitosis, late S and G2 phrases and inhibits topoisomerase II

64
Q

Etoposide (vepesid, VP-16)

A

-Epipodophyllotoxins
-Route:IV, oral
-Indication: cancer of bladder, lung, prostate, stomach, uterus, HD, NHL, Germ cell cancer
-Side effects: N/V/Diarrhea, mucositis, anorexia, metabolic taste during infusion

65
Q

Teniposide

A

Epipodophyllotoxins
Route: IV
Indication: Childhood ALL
Side effects: N/V

66
Q

Classification: Taxanes

A

mechanism of action
- active in mitosis phase of the cell cycle
-antimicrotubune agents which lead to inhibition of mitosis and cell division

67
Q

Paclitaxel (taxol)

A

-Taxanes
-Route: IV
-Indication: Bladder ,breast, esophagus,, HN, Lung, ovaries, pancreas, Prostate
-Side effects: N/V/D mucositis, peripheral neuropathy

68
Q

Docetaxel (taxotere)

A

-Taxanes
-Route: IV
-Indication: bladder, breast, HN, Lung, ovaries, prostate, stomach sarcoma
-Side effects: N/V/D/M

69
Q

Classification: Vinca Alkaloids

A

mechanism of action
-Bind protein tubulin disrupts mitotic spindle formation, prevent cell division mitosis phase

70
Q

Vincristine (oncavin)

A

-Vinca Alkaloids
-Route: IV
-Indication: ALL, AML, HD, NL
-side effects: constipation, abdominal, cramps, N taste changes, mucosit

71
Q

Vinblastine (Velban)
Vinorelbine

A

-vinca alkaloids
-Route: IV
-Indication: Bladder, breast, HN
-side effects: mucositis, stomatitis, constipation, taste change

72
Q

Target therapy

A

-1) Targets specific gen or protein found in cancer cells
-2) act on the tissue environment related to cancer cell growth and survival

73
Q

Monoclonal Antiboties

A

target specific receptors on the outside of the tumor cells that then activate pathways inside the cell to disrupt cell function and cause cell apoptosis (cell death)